HFA Premium Access

A restrictive pattern of LV filling is only present in one third of cardiac AL amyloidosis patients

Topic: HFpEF - Heart failure with preserved ejection fraction

Presentation

About the speaker

Professor Stefano Perlini

University of Pavia, Pavia (Italy)
0 follower

4 more presentations in this session

HfpEF 2020: opportunities to intervene

Speaker: Professor R. De Boer (Groningen, NL)

Thumbnail

Na+/Ca2+ Exchanger (NCX) inhibition with ORM 11035 improves cardiac function and remodeling without lowering blood pressure in a model of heart failure with preserved ejection fraction

Speaker: Professor F. Heinzel (Berlin, DE)

Thumbnail

Dipeptidyl peptidase 4 inhibitor sitagliptin reduces oxidative stress, endothelial dysfunction and preserves diastolic function in a rat model of heart failure with preserved ejection fraction

Speaker: Doctor K. Urbanek (Naples, IT)

Thumbnail

HFpEF and HFrEF display different anabolic phenotypes as assessed by IGF-1 and IGFBP-1

Speaker: Doctor U. Ljung Faxen (Stockholm, SE)

Thumbnail

Access the full session

Directions in HFpEF research

Speakers: Professor S. Perlini, Professor R. De Boer, Professor F. Heinzel, Doctor K. Urbanek, Doctor U. Ljung Faxen
Thumbnail

About the event

Image

HEART FAILURE 2016

21 May - 24 May 2016

Sessions Presentations

This platform is supported by

logo Novo Nordisk